Clinical Report: Assessment of Kappa Free Light Chain Index in MS
Overview
This study evaluates the diagnostic performance of the kappa free light chain (κ-FLC) index in multiple sclerosis (MS) and other inflammatory neurological disorders. The findings suggest that a higher κ-FLC index threshold improves diagnostic specificity for MS.
Background
Multiple sclerosis (MS) is characterized by inflammatory demyelination and requires accurate biomarkers for diagnosis. The κ-FLC index has emerged as a promising quantitative tool for assessing intrathecal immunoglobulin synthesis, which is critical for distinguishing MS from other inflammatory and non-inflammatory neurological disorders. Understanding the optimal cut-off values for the κ-FLC index is essential for enhancing diagnostic accuracy in clinical practice.
Data Highlights
{'MS/CIS': 'Specify median value', 'OIND': 'Specify median value', 'NIND': 'Specify median value'}
Key Findings
The median κ-FLC index was significantly higher in MS/CIS patients compared to OIND and NIND (p < 0.001).
The optimal κ-FLC index cut-off for distinguishing MS/CIS from OIND was 14.6, with a sensitivity of 73.5% and specificity of 68.1%.
A lower threshold of 6.1 provided higher sensitivity (85.7%) but lower specificity (35.4%).
Reiber’s diagram for κ-FLC synthesis showed the highest sensitivity (91.8%) but lower specificity (45.8%).
Higher κ-FLC index thresholds may improve diagnostic specificity in clinical settings.
Clinical Implications
The κ-FLC index serves as a valuable biomarker for assessing intrathecal immunoglobulin synthesis in MS. Clinicians should consider using higher cut-off values to enhance diagnostic specificity while being aware of the potential for false positives in other inflammatory disorders.
Conclusion
The κ-FLC index is a promising tool for diagnosing MS, with higher thresholds potentially improving diagnostic accuracy. Further validation in independent cohorts is warranted.
